Release date: 2025-06-06 10:20:10 Article From: Lucius Laos Recommended: 7
Knowing the correct dosage of abuxitinib is critical to improving the effectiveness of treatment.
The standard dose of abuxitinib is 100 mg once daily.
Doctors may adjust the dose on an individual basis, but it is generally not recommended to exceed this range.
For patients with hepatic insufficiency, the dose may need to be halved to 50 mg once daily. In older patients or those who are underweight, doctors may also recommend starting with a lower dose.
If a dose is missed, it should be retaken as soon as you remember, but you should not take a double dose on the same day. Overdose may cause adverse effects and require immediate medical attention.
The cost of treatment is one of the important considerations for patients when choosing a drug.
The market price of abuxitinib is approximately $1,500 per month, and the exact cost may vary by region and where it was purchased.
Some medical insurance plans may cover some of the costs, and patients should check with their insurance company in advance to understand the out-of-pocket ratio and reimbursement conditions.
Some pharmaceutical companies offer patient assistance programs where eligible low-income people may receive discounts on drugs or free treatment opportunities.
The correct use of abuxitinib should be combined with the guidance of the doctor, and the cost of treatment should be paid attention to to ensure the feasibility and effectiveness of long-term treatment.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2562024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:2432025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:2192025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:2452024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1992024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:2032024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1372024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:3052024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: